These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 33980265)

  • 1. MYLK4 promotes tumor progression through the activation of epidermal growth factor receptor signaling in osteosarcoma.
    Yang M; Zhang T; Zhang Y; Ma X; Han J; Zeng K; Jiang Y; Wang Z; Wang Z; Xu J; Hua Y; Cai Z; Sun W
    J Exp Clin Cancer Res; 2021 May; 40(1):166. PubMed ID: 33980265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TGFβ-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells.
    Wang T; Wang D; Zhang L; Yang P; Wang J; Liu Q; Yan F; Lin F
    J Exp Clin Cancer Res; 2019 May; 38(1):226. PubMed ID: 31138318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIAA1429 promotes osteosarcoma progression by promoting stem cell properties and is regulated by miR-143-3p.
    Han Q; Yang J; Yang H; Li C; Li J; Cao Y
    Cell Cycle; 2020 May; 19(10):1172-1185. PubMed ID: 32286148
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidermal growth factor receptor promotes tumor progression and contributes to gemcitabine resistance in osteosarcoma.
    Wang S; Wei H; Huang Z; Wang X; Shen R; Wu Z; Lin J
    Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(3):317-324. PubMed ID: 33432347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER4 promotes the growth and metastasis of osteosarcoma via the PI3K/AKT pathway.
    Li X; Huang Q; Wang S; Huang Z; Yu F; Lin J
    Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):345-362. PubMed ID: 32181480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-624-5p promoted tumorigenesis and metastasis by suppressing hippo signaling through targeting PTPRB in osteosarcoma cells.
    Luo Y; Liu W; Tang P; Jiang D; Gu C; Huang Y; Gong F; Rong Y; Qian D; Chen J; Zhou Z; Zhao S; Wang J; Xu T; Wei Y; Yin G; Fan J; Cai W
    J Exp Clin Cancer Res; 2019 Dec; 38(1):488. PubMed ID: 31829261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis.
    Duan G; Zhang C; Xu C; Xu C; Zhang L; Zhang Y
    Int J Oncol; 2019 Jan; 54(1):17-28. PubMed ID: 30365098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway.
    Shi D; Wu F; Mu S; Hu B; Zhong B; Gao F; Qing X; Liu J; Zhang Z; Shao Z
    J Exp Clin Cancer Res; 2019 Aug; 38(1):375. PubMed ID: 31443665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting nerve growth factor-mediated osteosarcoma metastasis: mechanistic insights and therapeutic opportunities using larotrectinib.
    Hou CH; Chen WL; Lin CY
    Cell Death Dis; 2024 May; 15(5):381. PubMed ID: 38816365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR-423-5p to activate Wnt5a/Ror2 signaling.
    Wan J; Liu Y; Long F; Tian J; Zhang C
    Cancer Sci; 2021 May; 112(5):1707-1722. PubMed ID: 33369809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p.
    Yang C; Wu K; Wang S; Wei G
    J Cell Biochem; 2018 Jul; 119(7):5646-5656. PubMed ID: 29384226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KDM6B-mediated histone demethylation of LDHA promotes lung metastasis of osteosarcoma.
    Jiang Y; Li F; Gao B; Ma M; Chen M; Wu Y; Zhang W; Sun Y; Liu S; Shen H
    Theranostics; 2021; 11(8):3868-3881. PubMed ID: 33664867
    [No Abstract]   [Full Text] [Related]  

  • 13. Crosstalk between ATF4 and MTA1/HDAC1 promotes osteosarcoma progression.
    Zeng H; Zhang JM; Du Y; Wang J; Ren Y; Li M; Li H; Cai Z; Chu Q; Yang C
    Oncotarget; 2016 Feb; 7(6):7329-42. PubMed ID: 26797758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of MicroRNA-489-3p promotes osteosarcoma metastasis by activating PAX3-MET pathway.
    Liu Q; Yang G; Qian Y
    Mol Carcinog; 2017 Apr; 56(4):1312-1321. PubMed ID: 27859625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAT2B promotes proliferation and inhibits apoptosis in osteosarcoma by targeting epidermal growth factor receptor and proliferating cell nuclear antigen.
    Yuan Y; Wang Y; Liu Z; Sun Y; Yao Y; Yu W; Shen Z
    Int J Oncol; 2019 Jun; 54(6):2019-2029. PubMed ID: 30942439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD248 promotes migration and metastasis of osteosarcoma through ITGB1-mediated FAK-paxillin pathway activation.
    Lu S; Lu T; Zhang J; Gan L; Wu X; Han D; Zhang K; Xu C; Liu S; Qin W; Yang F; Wen W
    BMC Cancer; 2023 Mar; 23(1):290. PubMed ID: 36997926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
    Zhang G; Li M; Jin J; Bai Y; Yang C
    Asian Pac J Cancer Prev; 2011; 12(8):2075-80. PubMed ID: 22292654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma.
    Shen Y; Zhao S; Wang S; Pan X; Zhang Y; Xu J; Jiang Y; Li H; Zhang Q; Gao J; Yang Q; Zhou Y; Jiang S; Yang H; Zhang Z; Zhang R; Li J; Zhou D
    EBioMedicine; 2019 Feb; 40():210-223. PubMed ID: 30587459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-221 Promotes Cell Proliferation and Inhibits Apoptosis in Osteosarcoma Cells by Directly Targeting FBXW11 and Regulating Wnt Signaling.
    Zhang Q; Yin X; Zhang Y
    Arch Med Res; 2021 Feb; 52(2):191-199. PubMed ID: 33131925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity.
    Zucchini C; Manara MC; Cristalli C; Carrabotta M; Greco S; Pinca RS; Ferrari C; Landuzzi L; Pasello M; Lollini PL; Gambarotti M; Donati DM; Scotlandi K
    J Exp Clin Cancer Res; 2019 Dec; 38(1):503. PubMed ID: 31878963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.